Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Arnav H. Tongaonkar"'
Publikováno v:
International Journal of Medicine and Health Development, Vol 28, Iss 2, Pp 167-172 (2023)
Background: Anticoagulants are among the most commonly used drugs in hospitalized patients known to cause adverse drug reactions (ADRs). They have commonly been used as standard therapy in venous thromboembolism, stroke prevention, etc. Objectives: T
Externí odkaz:
https://doaj.org/article/8026de596db14da592f56344ebb30a7c
Autor:
Arnav H Tongaonkar
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 6, Iss 2, Pp 308-310 (2023)
Externí odkaz:
https://doaj.org/article/824ae7d8d57d4a6fa9a5a3220981f70b
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 16, Iss 5, Pp OM01-OM06 (2022)
Introduction: Recent studies, both globally as well as in India, have depicted an alarming rise in the prevalence of Diabetes Mellitus (DM). Oral Hypoglycaemic Agents (OHAs) are the most common drugs used in the treatment of type 2 diabetes mellitus.
Externí odkaz:
https://doaj.org/article/bba8e078022a46b88726bf9dfc0bca3a
Autor:
Hasmukh Jain, Akhil Rajendra, Manju Sengar, Vasu Babu Goli, Jayashree Thorat, Hemanth Muthuluri, Arnav H. Tongaonkar, Kishore Kumar Kota, Himanshi Gupta, Neha Sharma, Thomas Eipe, Hiral Mehta
Publikováno v:
Expert review of anticancer therapy. 22(8)
AYA-ALL differs from pediatric ALL in terms of clinical, biological, psychosocial factors and access to care and has an inferior outcome. It is now being recognized that pediatric-inspired protocols are superior to adult protocols for this cohort, bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba3f20c3345a4353f402048a5d6d349
https://pubmed.ncbi.nlm.nih.gov/35734814
https://pubmed.ncbi.nlm.nih.gov/35734814